Can a single antibody turn down the immune storm in ARDS?
Disease control
Recruiting now
This trial tests whether an antibody called IC14 can reduce dangerous lung inflammation in people with acute respiratory distress syndrome (ARDS), a severe condition where the lungs fill with fluid. Hospitalized patients on a ventilator receive either IC14 or a placebo, and resea…
Phase 2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC